NEXTRAST, INC

Nextrast is a clinical-stage medical imaging company developing novel CT contrast agents to dramatically improve imaging capabilities. Its oral agent darkens the bowel lumen for superior anatomic delineation in oncology staging and inflammatory bowel disease, while its intravenous blood-pool agent enables prolonged vascular imaging for cardiovascular and liver applications. The company has completed Phase 2 clinical trials demonstrating detection of previously impossible-to-find bowel tumors.